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Introduction
Decontamination can be defined as "the process of removing hazardous material(s) both on or available to the external surfaces of the body in order to reduce local or systemic exposure to a contaminant and thus minimise the risk of subsequent adverse health effects" (Chilcott, 2014) . It is well established that a major route of exposure to chemical warfare (CW) agents is via contact with the skin (Evison, 2002) . The deliberate release of chemical warfare agents targeting civilian populations, exemplified by the sarin attacks in Tokyo (1995) and Syria (2014) (Eisenkraft, 2014; Okumura, 1996) , has led to the continued development of more effective decontamination strategies focused on dealing with civilian mass-casualty incidents (Amlot, 2010; Amlôt, 2017; Kassouf, 2017; Matar, 2016) .
Typically, decontamination strategies include physical removal or chemical neutralisation. Physical removal methodologies aim to remove contaminants, whereas chemical neutralisation aims to modify the structure of the contaminant in order to reduce or eliminate toxicity by hydrolysis, oxidation or metabolism (Chan, 2013) . The issue surrounding chemical neutralising agents is the lack of a single substance capable of neutralising compounds with a wide range of physiochemical properties and a potential for skin or eye irritation. Furthermore, it has been demonstrated that some neutralising products (e.g. bioscavengers) undergo stoichiometric reactions that result in rapid saturation (Nachon, 2013) . In certain cases, there is the potential to inadvertently produce toxic breakdown products, as observed with the degradation of VX (Munro, 1999) . A wide range of products have been evaluated for decontamination of surfaces (Capoun, 2014; Yang, 1992) ; however, few of these are suitable for skin decontamination (Salerno, 2016; Schwartz, 2012; Thors, 2017) , especially if the skin is damaged (Dalton, 2017; Lydon, 2017) . Given the lack of medical treatments for some chemical contami nants, such as sulphur mustard, decontamination can be used to mitigate toxic effects by reducing the contaminant and
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A C C E P T E D M A N U S C R I P T 4 removing it from skin, thus preventing or at least ameliorating the subsequent lesion severity (Chilcott, 2007; Hall, 2017) .
The objective of this current study was to extend the evaluation of five candidate products identified from a previous study (Matar, 2016) for the decontamination of chemical warfare agents. The rationale behind this work was to discover alternative products that could be used at the scene of an incident, prior to the deployment of specialised services, in conjunction with or in lieu of showering. A recent study demonstrated the effectiveness of using any absorptive material for decontamination (Kassouf, 2017) . However, the ability to retain these contaminants should be evaluated to prevent secondary contamination.
Materials and Methods

Chemicals
The storage and use of chemical warfare agents (CWA) was performed in full compliance with the chemical weapons conventions. CWA soman (GD), sulphur mustard (HD), VX and their ( 14 C) radiolabelled analogues were custom synthesised by TNO Defense, Security and Safety (Rijswijk, Netherlands) and were reported to be >97% pure. 
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Skin Samples
Full-thickness skin was obtained post mortem from female pigs (Sus scrofa, large white strain, weight range 15-25 kg) purchased from a reputable supplier. The skin was close clipped and excised from the dorsal aspect (full thickness) from each animal. The skin was then wrapped in aluminium foil and stored flat at -20°C for up to 3 months before use. Prior to the commencement of each experiment, a skin sample from a single animal was removed from cold storage and thawed in a refrigerator (4ºC) for approximately 24 hours. The skin was then dermatomed to a nominal depth of 500 μm using a Humeca Model D42, (Eurosurgical Ltd., Guildford, UK) and the thickness of the resulting skin section confirmed using a digital micrometer gauge (Tooled-Up, Middlesex, UK). Once dermatomed, the skin was cut into squares (3 × 3 cm) in preparation for mounting on to diffusion cells.
Diffusion Cells
Static skin diffusion cells were purchased from PermeGear (Chicago, Illinois, USA) and were based upon the design of the Franz diffusion cell (Franz, 1975 . Dermatomed skin sections were placed between the two chambers, with the epidermal surface facing the donor chamber, and the ensemble was securely clamped. The receptor chambers were filled with 50% (v/v) aqueous ethanol (14 ± 0.8 mL).
Each diffusion cell was placed in a Perspex™ holder above a magnetic stirrer which ACCEPTED MANUSCRIPT
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6 constantly mixed the receptor fluid via a (12 × 6 mm) Teflon™-coated iron bar placed within the receptor chamber. The receptor chambers were equipped with a jacket, through which warm (36ºC) water was pumped from a circulating water heater (Model GD120, Grant
Instruments, Cambridge, UK) via a manifold to ensure a constant skin surface temperature of 32ºC, as confirmed by infrared thermography (FLIR Model P620 camera, Cambridge, UK).
Once assembled, the diffusion cells were left in situ for an equilibration period of up to 24
hours.
Thirty-six diffusion cells were used in each experiment, divided into six treatment groups each comprising n=6 diffusion cells.
Experimental Procedure
Each experiment was initiated by the addition of either 10 μL ) to the skin surface of each diffusion cell.
Samples of receptor fluid (250 μL) were withdrawn from each diffusion cell at 3-hour intervals up to 24 h post exposure and were placed into vials containing 5 mL of LSC fluid.
Each receptor chamber was replenished with an equivalent volume (250 μL) of fresh fluid to maintain a constant volume in the receptor chamber.
Decontamination was conducted 5 minutes post exposure by the addition of 200 mg test product to each contaminated skin surface (where appropriate). Each product remained in situ for 24 hours, at which point they were removed and placed into 20 mL glass vials containing 20 mL LSC fluid. The contents of each receptor chamber were also removed and placed into 20 mL glass vials. Each skin surface was then swabbed with a dry gauze pad that was subsequently placed in 20 mL isopropanol. Finally, the skin samples from all diffusion cells were removed and placed into pre-weighed vials. The difference between the weight of each vial before and after addition of each skin sample allowed a calculation of the skin weight.
Each skin sample was then dissolved in 10 mL of Soluene-350.
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All vials were stored at room temperature (with occasional shaking) for up to 5 days, after which aliquots (250 μL) were removed and placed into vials containing 5 mL LSC fluid.
Standard solutions were prepared on the day of each experiment by the addition of 2 μL 
Liquid Scintillation Counting
The radioactivity in each sample was quantified using a PerkinElmer Tri-Carb liquid scintillation counter (Model 2810 TR), employing an analysis runtime of 2 minutes per sample and a pre-set quench curve specific to the brand of LSC fluid (Ultima Gold™). The amounts of radioactivity in each sample were converted to quantities of 
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Data Analysis
In order to permit an inter-experimental comparison of the performance of each treatment, the data were normalised relative to controls within each experiment using
%CD 24 = (QT 24 /QC 24 ) × 100 Eq. (1) where %CD 24 is the percentage of the control dose penetrating the skin, QT24 is the quantity of contaminant penetrating the skin at 24 hours following treatment (decontamination) and QC 24 is the quantity of contaminant penetrating control (untreated) skin at 24 hours.
The maximum rate of penetration (J max ) was calculated from the amount penetrated against time, which was averaged across the number of replicates. The time at which J max was achieved (T max ) was also averaged across all cells.
Statistical Analysis
A test for normality (Kolmogorov-Smirnov) was conducted on all data (per group) acquired from the in vitro studies: the data were found to be not normally distributed (nonGaussian) and so were analysed using non-parametric statistical tests. Treatment effects were analysed using the non-parametric equivalent of one-way analysis of variance (ANOVA; Kruskal-Wallis) followed by Dunn's post-test, allowing comparisons of each group against a control group. A probability level of p < 0.05 was the criterion for statistical significance throughout.
Results
All of the products evaluated (IA, TFMAA (Table 1) .
The amounts remaining on the skin surface at 24 hours were not significantly reduced by any of the decontaminants when compared to their respective controls (Table 2) . TFMAA, MBA and FA resulted in increased amounts of 14 C-GD remaining on the skin surface compared to controls, though the differences were not statistically significant.
There was no statistical difference between the amounts of 14 C-GD, HD or VX retained by each of the tested products when compared to FE (Table 3) .
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Discussion
Based upon the penetration profiles for each experiment in this study, it was difficult to discriminate between the products in terms of amount and rate of penetration of CWA.
However, some differences were apparent among the five remaining products: MBA did not significantly reduce J max or overall absorbed dose compared to any of the agents, and neither TFMAA nor Fast-Act® performed as well as FE or IA against 14 C-GD. Thus, the products that showed all round efficacy against all three CWA (soman, sulphur mustard and VX) and methyl salicylate (Matar, 2016) in terms of reduced J max and total amount penetrated were IA, FE, and TFMAA.
The main mechanism of action for the test products is absorption, with the exception of Fast-Act®, which combines absorption with the capability to neutralise chemical warfare agents via hydrolysis and or dehydrohalogenation (Lanz and Allen, 2004) . The molecularly imprinted polymers were designed to bind a range of chemicals with a relatively high affinity. However, further work is required to characterise any additional abilities, such as neutralisation.
One of the advantages of identifying an effective synthetic product is the ability to molecularly imprint these polymers into sponges or textiles. In recent years, there has been some scepticism over the suitability of aqueous-based decontamination systems, due to the phenomenon of a "wash-in" effect that can enhance chemical penetration through the skin (Idson, 1978; Moody and Nadeau, 1997; Zhai, 2002) . Studies comparing the effectiveness of washing the skin or using absorbent materials resulted in better efficacy when absorbent materials were employed (Amlôt, 2017; Kassouf, 2017; Lademann, 2011) . A further reason for developing a sponge or textile formulation is to mitigate possible issues surrounding the use of powder decontaminants, such as methods of application to the skin, containment and clear-up, in light of the dispersive properties of powders as well as their potential to be
inhaled (Waysbort, 2009 ). Furthermore, sponges may be more suitable for applications where the skin barrier is damaged or there are penetrating wounds, as studies have shown that reactive skin decontamination lotion is contraindicated for use on damaged skin (Walters, 2007) , while granular products such as fuller's earth are unsuitable for intra-wound use because of the risk of an inflammatory response and neurovascular injury (Gerlach, 2010) .
The methodology employed in this study requires some consideration. Although it is highly unlikely that a decontamination product could be administered 5 minutes post exposure in a mass-casualty incident, the authors wished to observe the efficacy of the decontamination agents under optimum conditions. In addition, the products were left on the skin surface for a relatively long duration (24 hours), in order to further evaluate their ability to retain the contaminant. Off-gassing and secondary hazards are serious issues in this type of CWA scenario, posing a potential risk to emergency workers and the general public after such events as the sarin attacks in the Tokyo subway, as well as the possible contamination of hospital staff who have to treat victims (Okumura, 1996) . A further limitation of this study was the use of radiolabelled chemicals without further chemical analysis to assess whether the agents were intact or a neutralised by-product. However, this represents a highly conservative approach to determining decontamination efficiency, as all measured radioactivity was assumed to be representative of the original toxic agent, rather than of any less toxic breakdown products.
Conclusions
All of the products evaluated in this study performed well in reducing the dermal absorption of all three chemical warfare agents. Further studies will evaluate more realistic exposure scenarios and decontamination efficacy investigated up to 6 hours post exposure, progressing to in vivo and human volunteer trials.
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Highlights:
 Five decontaminants were tested against chemical warfare agents applied to porcine skin.
 All achieved a marked reduction in the amount of contaminant within the skin.
 Early deployment of countermeasures may help mitigate skin absorption.
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